Amino Acid Infusion for Kidney Protection in Cardiac Surgery Patients with Chronic Kidney Disease: A Secondary Analysis of the PROTECTION Trial

医学 肾脏疾病 肾功能 急性肾损伤 安慰剂 内科学 肾脏替代疗法 胃肠病学 泌尿科 病理 替代医学
作者
Martina Baiardo Redaelli,Fabrizio Monaco,Nikola Bradić,Anna Mara Scandroglio,Lian Kah Ti,Alessandro Belletti,Cristina Viscido,Margherita Licheri,Fabio Guarracino,Alessandro Pruna,Antonio Pisano,Domenico Pontillo,Francesco Federici,Rosario Losiggio,Giovanni Serena,Enrico Tomasi,Simona Silvetti,Marco Ranucci,Luca Brazzi,Andrea Cortegiani
出处
期刊:Anesthesiology [Lippincott Williams & Wilkins]
被引量:2
标识
DOI:10.1097/aln.0000000000005336
摘要

Background: In the PROTECTION trial, intravenous amino acids (AA) decreased the occurrence of acute kidney injury (AKI) in cardiac surgery patients with cardiopulmonary bypass (CPB). Recruitment of renal functional reserve may be responsible for such protection. However, patients with chronic kidney disease (CKD) have diminished renal functional reserve, and AA may be less protective in such patients. Thus, a separate investigation of such patients is warranted. Methods: We defined CKD as an estimated glomerular filtration rate (eGFR)<60 mL·min -1 ·1.73 m -2 and patients with eGFR≥60 mL·min -1 ·1.73 m -2 served as controls. The primary outcome was the occurrence of AKI. Secondary outcomes included severity of AKI, need for and duration of renal replacement therapy, and all-cause mortality. Results: Among CKD patients (n=812), compared with placebo, AA significantly decreased the rate of AKI (43.1% vs 50.3%; RR, 0.86; 95%CI, 0.74 to 0.99; p=0.041; number needed to treat [NNT]=14) with a median percentage increase in eGFR from baseline to postoperative day three of 12.7% vs. 6.5% (p=0.002). In eGFR-based CKD subgroups (30 to 39, 40 to 49, and 50 to 59 mL·min -1 ·1.73 m -2 ) the AA effect was similar (interaction p=0.50). Finally, AA infusion decreased the occurrence of severe (stage 3) AKI (2.7% vs. 5.6%; RR 0.48; 95%CI, 0.24 to 0.98; p=0.038). Conclusions: AA infusion protected CKD patients undergoing CPB from developing AKI, with an absolute risk reduction of 7% and a NNT of 14 in a cohort with a >45% rate of AKI. Moreover, it delivered a >50% relative risk reduction in severe AKI.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
AKYDXS完成签到,获得积分10
1秒前
昏睡的蟠桃应助Llllll采纳,获得200
1秒前
科研通AI2S应助hao采纳,获得10
1秒前
2秒前
2秒前
香蕉觅云应助阿湫采纳,获得10
3秒前
星辰大海应助星辰采纳,获得10
3秒前
阿卡宁完成签到,获得积分10
3秒前
lzw完成签到 ,获得积分10
3秒前
沉静烧仙草完成签到,获得积分20
4秒前
烟花应助嘉嘉琦采纳,获得10
4秒前
隐形曼青应助科研通管家采纳,获得10
4秒前
Hello应助科研通管家采纳,获得10
5秒前
Ava应助科研通管家采纳,获得10
5秒前
上官若男应助科研通管家采纳,获得10
5秒前
5秒前
赘婿应助科研通管家采纳,获得10
5秒前
烟花应助科研通管家采纳,获得10
5秒前
FashionBoy应助科研通管家采纳,获得10
5秒前
英俊的铭应助科研通管家采纳,获得10
5秒前
在水一方应助科研通管家采纳,获得10
5秒前
accepted应助科研通管家采纳,获得10
5秒前
脑洞疼应助科研通管家采纳,获得10
5秒前
5秒前
cdh1994应助kcmat采纳,获得10
5秒前
我是老大应助科研通管家采纳,获得10
5秒前
乐乐应助科研通管家采纳,获得10
5秒前
FashionBoy应助科研通管家采纳,获得10
5秒前
5秒前
上官若男应助科研通管家采纳,获得10
5秒前
5秒前
5秒前
5秒前
我是老大应助科研通管家采纳,获得30
5秒前
脑洞疼应助科研通管家采纳,获得20
6秒前
科目三应助科研通管家采纳,获得30
6秒前
6秒前
完美世界应助科研通管家采纳,获得10
6秒前
6秒前
6秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
Research on Disturbance Rejection Control Algorithm for Aerial Operation Robots 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038524
求助须知:如何正确求助?哪些是违规求助? 3576221
关于积分的说明 11374737
捐赠科研通 3305912
什么是DOI,文献DOI怎么找? 1819354
邀请新用户注册赠送积分活动 892688
科研通“疑难数据库(出版商)”最低求助积分说明 815048